|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
˿״��� |
|
�����ҩ |
|
������������ |
| ��������������� | |
|
��ƽ |
|
����� |
| PubMed | |
|
Article by ��ƽ |
|
Article by ����� |
����˿״�������ҩ�����鷽��������о���չ
��ƽ1, �����2
1. ������·��ҽԺƤ����, 100038;
2. ������ѧ��һ�ٴ�ҽѧԺƤ����
��������M38-P�������ڲ���˿״�������ҩ����������,��Ӧ�÷�Χ�������ֶΡ��յ��ж����������������о���չ,�����˲���˿״�������ҩ�����鷽����Ӧ��,Ϊ�ٴ����ƻ����������Ⱦ�ṩ����ָ���������ҩѡ���Ч��Ԥ��.
1. ������·��ҽԺƤ����, 100038;
2. ������ѧ��һ�ٴ�ҽѧԺƤ����
1. ������·��ҽԺƤ����, 100038;
2. ������ѧ��һ�ٴ�ҽѧԺƤ����
[2] Denning DW,Radford SA,Oakley KL,et al.Correlation between invitro susceptibility testing to itraconazole and invivo outcome of Aspergillus fumigatus infection.J Antimicrob Chemother,1997,40(3):401-414.
[3] Manavathu EK,Cutright J,Chandrasekar PH.Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.J Clin Microbiol,1999,37(3):858-861.
[4] Pfaller MA,Messer SA,Mills K,et al.In vitro susceptibility testing of filamentous fungi:comparison of Etest and reference microdilutionmethods for determining itraconazole MICa.J Clin Microbiol,2000,38(9):3359-2261.
[5] Szekely A,Johnson EM,Warnock DW.Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds.J Clin Microbiol,1999,37(5):1480-1483.
[6] Espinel-Ingroff A.Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.J Clin Microbiol,2001,39(4):1360.
[7] Hopfer RL,Sparks SD,Cox GM.The use of flow cytometry as a tool for monitoring filament formation of fungi.Med Mycol,2001,39(1):103-107.
[8] Wenisch C,Linnau KF,Parschalk B,et al.Rapid susceptibility testing of fungi by flow cytometry using vital staining.J Clin Microbiol,1997,35(1):5-10.
[9] Balajee SA,Marr KA.Conidial viability assay for rapid susceptibility testing of Aspergillus species.J Clin Microbiol,2002,40(8):2741.
[10] Meletiadis J,Meis JF,Mouton JW,et al.Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2,5-diphenyl-2H-tetrazolium bromide(MTT)methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method.J Clin Microbiol,2000,38(8):2949-2954.
[11] Meletiadis J,Mouton JW,Meis JF,et al.Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt,2,3-bis {2-methoxy-4-nitro-5-[(sulfenylamino)carbonyl]-2Htetrazolium-hydroxide},for antifungal susceptibility testin g of Aspergillus species.J Clin Microbiol,2001,39(12):4256-4263.
[12] Meletiadis J,Mouton JW,Meis JF,et al.Colorimetric assay for antifungal susceptibility testing of Aspergillus species.J Clin Microbiol,2001,39(9):3402-3408.
[13] Rex JH,Pfaller MA,Galgiani JN,et al.Development of interpretive breakpoints for antifungal susceptibility testing:conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole,itraconazole,and candida infections.Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.Clin Infect Dis,1997,24(2):235-247.
[14] Dixon DM,Polak A.In vitro and in vivo drug studies with three agents of central nervous system phaeohyphomycosis.Chemotherapy,1987,33(2):129-140.
[15] Odds FC,Van Gerven F,Espinel-Ingroff A,et al.Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.Antimicrob Agents Chemother,1998,42(2):282-288.
[16] Lass-Florl C,Kofler G,Kropshofer G,et al.In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.J Antimicrob Chemother,1998,42(4):497.
[17] Barchiesi F,Falconi Di Francesco L,Scalise G.In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.Antimicrob Agents Chemother,1997,41(8):1812-1814.
[18] Ryder NS,Leitner I.Synergistic interaction of terbinafine with triazolesor amphoteriein B against Aspergillus species.Med Mycol,2001,39(1):91-95.
[19] Kontoyiannis DP,Lewis RE,Sagar N,et al.Itraconazole-amphotericin B antagonism in Aspergillus fumigatus:an E-test-based strategy.Antimicrob Agents Chemother,2000,44(10):2915-2918.
[20] Te Dorsthorst DT,Verweij PE,Meis JF.et al.Comparison of fracional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and-resistant Aspergillus fumigatus isolates.Antimicrob Agents Chemother,2002,46(3):702-707.